Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: Soy isoflavone capsule, 50 mg, daily for 12 weeks orally. Intervention 2: Control group: Placebo capsule, daily for 12 weeks orally.
Treatment - Drugs
Intervention group: Soy isoflavone capsule, 50 mg, daily for 12 weeks orally.
Sponsors
Vice chancellor for research, Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with PCOS according to Rotterdam criteria; higher than 5 years of their disease; aged 18 to 40 years. Exclusion criteria: Unwillingness to cooperate.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.;Triglycerides. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hs-CRP. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed